Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease-Reference-Cited by-同舟云学术

Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease

Published:2019-08 Issue:3 Volume:39 Page:321-334
ISSN:0889-8561
Container-title:Immunology and Allergy Clinics of North America
language:en
Short-container-title:Immunology and Allergy Clinics of North America

Author:

San-Juan-Vergara Homero,Peeples Mark E.

Funder

NIH

Cystic Fibrosis Foundation

Janssen

Pfizer

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization;Chanock;Am J Hyg,1957

2. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine;Kapikian;Am J Epidemiol,1969

3. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine;Prince;J Gen Virol,2001

4. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10;Connors;J Virol,1994

5. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group;IMpact-RSV;Pediatrics,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants;Vaccine;2024-11

2. Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024);Vaccines;2024-06-08

3. RSV disease in infants and young children: Can we see a brighter future?;Human Vaccines & Immunotherapeutics;2022-06-20

4. Targeting Molecular and Cellular Mechanism in Rhinovirus Infection;Targeting Cellular Signalling Pathways in Lung Diseases;2021

5. Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries;Expert Review of Anti-infective Therapy;2020-12-08